Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wesley

Showing results (321-330 of 354) with videos related to

Pageof 36
Sort By:
Biorxiv : the Preprint Server for Biology|September 25, 2023
A mutation in <i>Themis</i> contributes to peanut-induced oral anaphylaxis in CC027 miceEllen L Risemberg, Johanna M Smeekens, Marta C Cruz Cisneros, et al.
The Journal of Allergy and Clinical Immunology|December 8, 2020
Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy ResearchAmy M Scurlock, A Wesley Burks, Scott H Sicherer, et al.
The Journal of Allergy and Clinical Immunology|March 1, 2016
Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapyStacie M Jones, A Wesley Burks, Corinne Keet, et al.
The Journal of Allergy and Clinical Immunology|October 15, 2021
Allergen-specific T cells and clinical features of food allergy: Lessons from CoFAR immunotherapy cohortsM Cecilia Berin, Charuta Agashe, A Wesley Burks, et al.
Frontiers in Immunology|February 5, 2021
Fecal IgA, Antigen Absorption, and Gut Microbiome Composition Are Associated With Food Antigen Sensitization in Genetically Susceptible MiceJohanna M Smeekens, Brandi T Johnson-Weaver, Andrew L Hinton, et al.
The Journal of Allergy and Clinical Immunology|August 15, 2016
Early oral immunotherapy in peanut-allergic preschool children is safe and highly effectiveBrian P Vickery, Jelena P Berglund, Caitlin M Burk, et al.
The Journal of Allergy and Clinical Immunology|January 17, 2017
Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adultsStacie M Jones, Scott H Sicherer, A Wesley Burks, et al.
The Journal of Allergy and Clinical Immunology|December 24, 2013
Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapyBrian P Vickery, Amy M Scurlock, Michael Kulis, et al.
Nature Chemical Biology|February 16, 2023
Structural basis of paralog-specific KDM2A/B nucleosome recognitionCathy J Spangler, Aleksandra Skrajna, Caroline A Foley, et al.
The Journal of Allergy and Clinical Immunology|January 19, 2002
Factors affecting the determination of threshold doses for allergenic foods: how much is too much?Steve L Taylor, Susan L Hefle, Carsten Bindslev-Jensen, et al.
Pageof 36

Showing results (321-330 of 354) with videos related to

Sort By:
Pageof 36
Biorxiv : the Preprint Server for Biology|September 25, 2023
A mutation in <i>Themis</i> contributes to peanut-induced oral anaphylaxis in CC027 miceEllen L Risemberg, Johanna M Smeekens, Marta C Cruz Cisneros, et al.
The Journal of Allergy and Clinical Immunology|December 8, 2020
Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy ResearchAmy M Scurlock, A Wesley Burks, Scott H Sicherer, et al.
The Journal of Allergy and Clinical Immunology|March 1, 2016
Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapyStacie M Jones, A Wesley Burks, Corinne Keet, et al.
The Journal of Allergy and Clinical Immunology|October 15, 2021
Allergen-specific T cells and clinical features of food allergy: Lessons from CoFAR immunotherapy cohortsM Cecilia Berin, Charuta Agashe, A Wesley Burks, et al.
Frontiers in Immunology|February 5, 2021
Fecal IgA, Antigen Absorption, and Gut Microbiome Composition Are Associated With Food Antigen Sensitization in Genetically Susceptible MiceJohanna M Smeekens, Brandi T Johnson-Weaver, Andrew L Hinton, et al.
The Journal of Allergy and Clinical Immunology|August 15, 2016
Early oral immunotherapy in peanut-allergic preschool children is safe and highly effectiveBrian P Vickery, Jelena P Berglund, Caitlin M Burk, et al.
The Journal of Allergy and Clinical Immunology|January 17, 2017
Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adultsStacie M Jones, Scott H Sicherer, A Wesley Burks, et al.
The Journal of Allergy and Clinical Immunology|December 24, 2013
Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapyBrian P Vickery, Amy M Scurlock, Michael Kulis, et al.
Nature Chemical Biology|February 16, 2023
Structural basis of paralog-specific KDM2A/B nucleosome recognitionCathy J Spangler, Aleksandra Skrajna, Caroline A Foley, et al.
The Journal of Allergy and Clinical Immunology|January 19, 2002
Factors affecting the determination of threshold doses for allergenic foods: how much is too much?Steve L Taylor, Susan L Hefle, Carsten Bindslev-Jensen, et al.
Pageof 36